Quantcast
Connect with us

Drug makers are jacking up prices months after Trump boasted they were rolling them back at his request

Published

on

Big Pharma companies are announcing that they are jacking up drug prices just months after President Donald Trump took to Twitter and boasted that they would roll them back or hold them down at his request.

Just as car manufacturers are shuttering plants after Trump claimed that he was responsible for a surge in manufacturing jobs, drug manufacturers such as Pfizer and Merck announced this week that they will increase pricing — contrary to Trump’s promise of price decreases.

ADVERTISEMENT

According to business columnist Micheal Hiltzik of the Los Angeles Times, the manufacturers pulled a fast one when they told Trump they would defer planned price increases back in May, only to drop the bomb before the end of the year.

On July 10th, Trump tweeted: “Just talked with Pfizer CEO and @SecAzar on our drug pricing blueprint. Pfizer is rolling back price hikes, so American patients don’t pay more. We applaud Pfizer for this decision and hope other companies do the same. Great news for the American people!”

ADVERTISEMENT

But industry observers point out that Trump lied when he bragged about prices “rolling back.”

As Hiltzik writes, “Instead, the company said it would ‘defer’ price increases on 41 drug formulations it had scheduled for July 1 until either Trump’s ‘blueprint to lower drug prices’ went into effect or the end of the year, whichever came sooner.”

He points out that Peter Maybarduk of advocacy group Public Citizen noted at the time, “Pfizer is only deferring price increases — not canceling them, and certainly not lowering its prices.”

ADVERTISEMENT

According to University of Pittsburgh pharmaceutical policy expert Walid Gellad, drug companies humored the president while making plans to go ahead with raising prices after getting kudos from Trump.

“Making promises to the president is not how you fix a fundamental market problem,” Gellad explained.

The Times report notes that Merck manipulated public opinion — and possibly the president — by playing fast and loose with the truth.

ADVERTISEMENT

“Merck, in its July 20 announcement of price cuts, built itself a rather more elaborate loophole. The company said it would not increase the average net price of its entire portfolio of drugs by more than inflation annually,” Hikltzik wrote. “It dressed up the announcement by lowering the price of Zepatier, a hepatitis C treatment, by 60% and of six other drugs by 10%.”

He then noted that the seven drugs listed were small, unpopular and unprofitable formulations that account for very little of their sales, writing, “Zepatier sales had fallen so low by the first quarter of this year that Merck listed the drug’s U.S. sales in its quarterly financial report as essentially zero.”

Addressing just Merck’s announced increase, and using its 2017 revenues as a guide, Hiltzik said the announced increases “will fatten Merck’s profits by about $357 million, or 15%.”

ADVERTISEMENT

You can read more here.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump has figured out how to get taxpayers to renovate one of his golf courses: MSNBC panel

Published

on

President Donald Trump has figured out how to have taxpayers pay to renovate his Trump National Doral Miami golf course, according to an analysis by MSNBC's Stephanie Ruhle.

"Before setting himself on fire on Ukraine yesterday, Mick Mulvaney came into the White House briefing room to break to the nation the fact the that the Trump Doral golf resort turns out to be -- in his estimation, organically, just sitting there -- the best possible place to have a G-7 Summit of world leaders," MSNBC's Brian Williams reported. "That was provision number one. There’s no better place that we can find. Number two was, the president will not profit from said G-7."

Continue Reading

Breaking Banner

Bill Maher reveals plan to ‘bribe’ Trump with one billion dollars — for him to leave office

Published

on

The Constitution has two mechanisms to remove President Donald Trump from office prior to his term ending on January 20, 2021: impeachment and the 25th Amendment.

HBO "Real Time" host Bill Maher noted that Trump could also choose to resign.

Maher waved around a $1 million check that he said he would give to Trump to quit.

He said he also knew 1,000 people who would do the same -- which would land Trump over $1 billion.

Maher said even poor people would pawn their wedding rings to add to the pot.

Watch:

Continue Reading
 

Breaking Banner

Trump can’t fire Mulvaney because nobody else wants to be his chief of staff: report

Published

on

White House Chief of Staff Mick Mulvaney will likely stay on at the White House despite his public confession of a quid pro quo in the Ukraine scandal at the center of the impeachment inquiry, The New York Times reported Friday.

"But Mr. Mulvaney’s job has been anything but normal since the news conference on Thursday at which he seemingly undermined the Trump administration’s strategy for avoiding impeachment by acknowledging that Mr. Trump had sought a quid pro quo for providing Ukraine with American aid," the newspaper reported. "In the chaotic aftermath, the president’s Republican allies are questioning Mr. Mulvaney’s savvy and intelligence even as the Trump campaign is defiantly turning one of his lines from the news conference into a T-shirt."

Continue Reading
 
 
Help Raw Story Uncover Injustice. Join Raw Story Investigates for $1 and go ad-free.
close-image